207 related articles for article (PubMed ID: 19799958)
1. Analysis of in vitro toxicity of five cell-penetrating peptides by metabolic profiling.
Kilk K; Mahlapuu R; Soomets U; Langel U
Toxicology; 2009 Nov; 265(3):87-95. PubMed ID: 19799958
[TBL] [Abstract][Full Text] [Related]
2. Cell-penetrating peptides: a comparative membrane toxicity study.
Saar K; Lindgren M; Hansen M; Eiríksdóttir E; Jiang Y; Rosenthal-Aizman K; Sassian M; Langel U
Anal Biochem; 2005 Oct; 345(1):55-65. PubMed ID: 16137634
[TBL] [Abstract][Full Text] [Related]
3. Cell-penetrating peptides: mechanism and kinetics of cargo delivery.
Zorko M; Langel U
Adv Drug Deliv Rev; 2005 Feb; 57(4):529-45. PubMed ID: 15722162
[TBL] [Abstract][Full Text] [Related]
4. Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications.
Kamide K; Nakakubo H; Uno S; Fukamizu A
Int J Mol Med; 2010 Jan; 25(1):41-51. PubMed ID: 19956900
[TBL] [Abstract][Full Text] [Related]
5. Non-metabolic membrane tubulation and permeability induced by bioactive peptides.
Lamazière A; Burlina F; Wolf C; Chassaing G; Trugnan G; Ayala-Sanmartin J
PLoS One; 2007 Feb; 2(2):e201. PubMed ID: 17299584
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of cell-penetrating peptide-mediated peptide delivery.
Jones SW; Christison R; Bundell K; Voyce CJ; Brockbank SM; Newham P; Lindsay MA
Br J Pharmacol; 2005 Aug; 145(8):1093-102. PubMed ID: 15937518
[TBL] [Abstract][Full Text] [Related]
7. CyLoP-1: a novel cysteine-rich cell-penetrating peptide for cytosolic delivery of cargoes.
Jha D; Mishra R; Gottschalk S; Wiesmüller KH; Ugurbil K; Maier ME; Engelmann J
Bioconjug Chem; 2011 Mar; 22(3):319-28. PubMed ID: 21319732
[TBL] [Abstract][Full Text] [Related]
8. Cell-surface thiols affect cell entry of disulfide-conjugated peptides.
Aubry S; Burlina F; Dupont E; Delaroche D; Joliot A; Lavielle S; Chassaing G; Sagan S
FASEB J; 2009 Sep; 23(9):2956-67. PubMed ID: 19403512
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of cell-penetrating peptides for cargo delivery.
Pooga M; Langel U
Methods Mol Biol; 2005; 298():77-89. PubMed ID: 16044541
[TBL] [Abstract][Full Text] [Related]
10. Study of uptake of cell penetrating peptides and their cargoes in permeabilized wheat immature embryos.
Chugh A; Eudes F
FEBS J; 2008 May; 275(10):2403-14. PubMed ID: 18397318
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA).
Bendifallah N; Rasmussen FW; Zachar V; Ebbesen P; Nielsen PE; Koppelhus U
Bioconjug Chem; 2006; 17(3):750-8. PubMed ID: 16704214
[TBL] [Abstract][Full Text] [Related]
12. Predicting cell-penetrating peptides.
Hansen M; Kilk K; Langel U
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):572-9. PubMed ID: 18045726
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric screening of cell-penetrating peptides for their uptake into embryonic and adult stem cells.
Manceur A; Wu A; Audet J
Anal Biochem; 2007 May; 364(1):51-9. PubMed ID: 17379177
[TBL] [Abstract][Full Text] [Related]
14. Cargo delivery kinetics of cell-penetrating peptides.
Hällbrink M; Florén A; Elmquist A; Pooga M; Bartfai T; Langel U
Biochim Biophys Acta; 2001 Dec; 1515(2):101-9. PubMed ID: 11718666
[TBL] [Abstract][Full Text] [Related]
15. Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents.
Abes S; Moulton HM; Clair P; Prevot P; Youngblood DS; Wu RP; Iversen PL; Lebleu B
J Control Release; 2006 Dec; 116(3):304-13. PubMed ID: 17097177
[TBL] [Abstract][Full Text] [Related]
16. Live-cell analysis of cell penetration ability and toxicity of oligo-arginines.
Tünnemann G; Ter-Avetisyan G; Martin RM; Stöckl M; Herrmann A; Cardoso MC
J Pept Sci; 2008 Apr; 14(4):469-76. PubMed ID: 18069724
[TBL] [Abstract][Full Text] [Related]
17. Cell-penetrating peptides, PepFects, show no evidence of toxicity and immunogenicity in vitro and in vivo.
Suhorutsenko J; Oskolkov N; Arukuusk P; Kurrikoff K; Eriste E; Copolovici DM; Langel U
Bioconjug Chem; 2011 Nov; 22(11):2255-62. PubMed ID: 21978260
[TBL] [Abstract][Full Text] [Related]
18. Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules.
De Coupade C; Fittipaldi A; Chagnas V; Michel M; Carlier S; Tasciotti E; Darmon A; Ravel D; Kearsey J; Giacca M; Cailler F
Biochem J; 2005 Sep; 390(Pt 2):407-18. PubMed ID: 15859953
[TBL] [Abstract][Full Text] [Related]
19. Delivery of nucleic acids with a stearylated (RxR)4 peptide using a non-covalent co-incubation strategy.
Lehto T; Abes R; Oskolkov N; Suhorutsenko J; Copolovici DM; Mäger I; Viola JR; Simonson OE; Ezzat K; Guterstam P; Eriste E; Smith CI; Lebleu B; Samir El Andaloussi ; Langel U
J Control Release; 2010 Jan; 141(1):42-51. PubMed ID: 19744531
[TBL] [Abstract][Full Text] [Related]
20. Distinct uptake routes of cell-penetrating peptide conjugates.
Lundin P; Johansson H; Guterstam P; Holm T; Hansen M; Langel U; EL Andaloussi S
Bioconjug Chem; 2008 Dec; 19(12):2535-42. PubMed ID: 19012426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
